ASS1 and metabolic dysfunction-associated steatotic liver disease: We postulate that in the context of chronic intermittent hypoxia triggering inflammatory cascades, the ensuing hyperinflammation hampers ASS1 expression, culminating in liver injury and NAFLD pathogenesis.